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Abstract
Chronic neuropathic pain originates from the
damaged sensory nervous system and
remains a major clinical challenge despite
multiple clinical studies. Existing literature
suggests an altered expression of pain
associated genes (PAGs) following nerve
injury and involves epigenetic modifications
in dorsal root ganglion (DRG). The protein
arginine methyltransferase 5 (PRMT5) is
predominantly expressed in neuronal cells
and catalyzes arginine methylation of
histones and many non-histone proteins.
However, it remains unclear if such
methylation events also occur after nerve
injury and pain sensation. Earlier reports
suggest an increased expression of the
repressor element-1 silencing transcription
factor (REST) in DRGs after nerve injury–
which
contributes
to
transcriptional
repression of various genes and results in
the development of chronic pain.
We hypothesize that spared nerve injury
(SNI)-induced chronic pain involves RESTmediated silencing of PRMT5. As a first step
of this mechanism, we asked whether
PRMT5 expression inversely correlates with
REST in mice DRG after SNI. We used wildtype and Rest conditional knock-out (cKO)
mice with various biochemical techniques.

Introduction
Nerve injury leads to many physiological
changes
including
an
increase
in
inflammation and localized sensitivity to
various stimuli. Studies have shown that
REST is upregulated in sensory neurons
after SNI and is necessary for the
development of chronic pain. Using a Rest
cKO mouse line, researchers found reduced
levels of chronic pain after SNI when Rest
was deleted—suggesting that it is a critical
factor in the development of chronic pain2.
REST is a major chromatin modifier which
contains a DNA binding domain which binds
to the consensus REI sequence. It contains
two repressor domains (RD1 and RD2)
which bind to many corepressors including
Co-REST,
HDAC1,
2,
etc.
These
corepressors help REST modify chromatin
around its target genes.
Mechanistically, PRMTs are enzymes which
catalyze the methylation of various arginine
residues within proteins. Catalyzation of
arginine residues is made possible through
transfers from the S-adenosylmethionine
(SAM)
substrate
which
results
in
monomethylated arginine (MMA) and Sadenosylhomocysteine
(SAH).
Further,
catalyzation of MMA is dependent on the
type of PRMT, with Type II enzymes such as
PRMT5 being able to catalyze the
monomethylation
to
asymmetric
dimethylarginine (sDMA)3.

Methods

Fig. 3 Tactile threshold post-SNI between control and
SNI tracked over a period of 27 days (A). Tactile
threshold between (1) injured and uninjured and (2)
REST cKO injured and uninjured DRGs post-SNI
tracked over a period of 29 days (B). Rest cKO mice
were able to significantly recover from pain when
compared to +SNI mice

Fig. 6 Quantification of protein expression of REST and
PRMT5 levels in the L3 and L4 DRGs from SNI in wild
type and REST cKO mice
Here, a significant overexpression of REST was
observed in the injured (+SNI) compared to the
uninjured (-SNI). Further, down regulation of PRMT5
protein expression between injured DRGs and uninjured
DRGs was observed.

The L3-L4 DRGs and spinal cord tissues
obtained from wild type (WT) and Rest cKO
mice before and after SNI on the left limb were
used for quantitative real time PCR (qRT-PCR)
and western blotting. No SNI (sham) was
performed on the right limb of the mice. The
REST binding site on the PRMT5 promoter was
bioinformatically predicted by MatInspector
(Genomatix).

Results
The initial qPCR results suggested an above
3.5-fold increase of REST mRNA with
concurrent reduction in PRMT5 mRNA levels
in the SNI compared to uninjured DRGs. The
reduction of PRMT5 expression with
increased levels of REST in DRGs after SNI
was also confirmed by western blotting. In
the Rest cKO mice, SNI did not affect
PRMT5 protein levels, suggesting REST
plays a role in regulating PRMT5. The
predicted binding site of REST in the mouse
PRMT5 promoter was located at the -369 to 339 region proximal to the transcription start
site

Fig. 4 Quantification of REST and PRMT5 protein levels
in the L3 and L4 DRGs and SNI dorsal spinal cord
A significant overexpression of REST observed in
injured (+SNI) compared to uninjured (-SNI) (p<0.01).
Moreover, protein expression of REST and PRMT5 were
not altered in the dorsal spinal cord side

Conclusions
Our findings suggest a potential role of
REST in negatively regulating PRMT5
expression in the DRGs after SNI. A
potential binding site of REST is observed
in the PRMT5 promoter; however, further
validation of this binding is needed.
Overall, elucidating the role of PRMT5
downregulation in epigenetic alteration of
PRGs could unravel a novel mechanism
of arginine methylation in chronic pain
development.

Fig. 7 Quantification of mRNA levels of REST and
PRMT5 in the L3 and L4 DRGs
Quantification of mRNA levels shows a significant
overexpression of REST and down regulation of PRMT5
being observed in injured (+SNI) compared to uninjured
(-SNI) DRGs. Further, +SNI in Rest cKO mice caused
overexpression of PRMT5 in DRGs.

Fig. 8 Predicted binding site of REST in the mouse
PRMT5 promoter was located at -369 to -339 region
proximal to the transcription start site
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